tiprankstipranks
China Literature Ltd. (HK:0772)
:0772
Want to see HK:0772 full AI Analyst Report?

China Literature (0772) AI Stock Analysis

5 Followers

Top Page

HK:0772

China Literature

(0772)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - Gpt-5.6Sol)
Rating:53Neutral
Price Target:
HK$22.00
▲(9.56% Upside)
Action:Reiterated
Date:09/06/26
The score is held back primarily by weakening financial performance—losses and a sharp deterioration in cash flow—despite a strong, low-leverage balance sheet. Technicals provide some support in the near term, but the longer-term downtrend remains a headwind. Valuation is also constrained by negative earnings and the absence of a dividend yield in the provided data.
Positive Factors
Integrated IP business model
The combination of digital reading and downstream IP licensing gives China Literature multiple ways to monetize original works. Successful titles can generate value beyond initial reader payments through adaptations and related commercialization, supporting a scalable content ecosystem.
Negative Factors
Deepening net losses
The move from profitability into substantially larger losses indicates that the current cost base and spending levels are not being covered by gross profit. Persistent losses would weaken retained equity, limit reinvestment capacity, and make sustainable earnings recovery more dependent on execution.
Read all positive and negative factors
Positive Factors
Negative Factors
Integrated IP business model
The combination of digital reading and downstream IP licensing gives China Literature multiple ways to monetize original works. Successful titles can generate value beyond initial reader payments through adaptations and related commercialization, supporting a scalable content ecosystem.
Read all positive factors

China Literature (0772) vs. iShares MSCI Hong Kong ETF (EWH)

China Literature Business Overview & Revenue Model

Company Description
China Literature Limited is a major investment holding company that manages a leading digital literature platform across the People's Republic of China. It strategically monetizes its extensive catalog of intellectual properties (IPs) through key ...
How the Company Makes Money
China Literature primarily generates revenue through (1) online reading and related digital content services and (2) monetization of its IP portfolio beyond reading. In online reading, the company earns money from paid reading (users paying to acc...

China Literature Financial Statement Overview

Summary
Overall fundamentals are mixed: the balance sheet is strong with very low leverage and solid equity (Balance Sheet Score 78), but operating performance has deteriorated with volatile revenue and a swing into larger losses (Income Statement Score 44). Cash generation also weakened sharply with operating and free cash flow turning negative in the latest year (Cash Flow Score 39).
Income Statement
44
Neutral
Balance Sheet
78
Positive
Cash Flow
39
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.66B7.37B8.12B7.01B7.63B8.67B
Gross Profit3.69B3.54B3.92B3.37B4.03B4.60B
EBITDA464.41M641.81M748.35M1.22B1.20B1.12B
Net Income-1.49B-776.05M-209.22M804.88M608.19M1.85B
Balance Sheet
Total Assets21.31B21.59B22.95B23.19B22.73B23.30B
Cash, Cash Equivalents and Short-Term Investments7.65B7.73B7.62B6.28B7.51B7.21B
Total Debt156.51M181.43M166.21M238.10M617.98M1.45B
Total Liabilities3.83B4.06B4.57B4.16B4.78B6.11B
Stockholders Equity17.47B17.53B18.37B19.02B17.96B17.19B
Cash Flow
Free Cash Flow350.63M-365.16M2.41B954.13M1.25B879.35M
Operating Cash Flow396.68M-276.51M2.53B1.13B1.58B1.12B
Investing Cash Flow436.63M-1.06B-1.76B-3.39B528.10M936.23M
Financing Cash Flow-232.57M-225.94M-346.01M-510.82M-1.15B-349.99M

China Literature Technical Analysis

Technical Analysis Sentiment
Positive
Last Price20.08
Price Trends
50DMA
20.20
Positive
100DMA
22.25
Negative
200DMA
27.96
Negative
Market Momentum
MACD
0.12
Negative
RSI
56.99
Neutral
STOCH
41.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0772, the sentiment is Positive. The current price of 20.08 is below the 20-day moving average (MA) of 20.95, below the 50-day MA of 20.20, and below the 200-day MA of 27.96, indicating a neutral trend. The MACD of 0.12 indicates Negative momentum. The RSI at 56.99 is Neutral, neither overbought nor oversold. The STOCH value of 41.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0772.

China Literature Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
HK$3.99T14.6420.47%1.20%15.97%18.45%
74
Outperform
HK$5.01B11.893.92%5.16%-6.86%379.60%
69
Neutral
HK$13.12B5.088.15%8.95%1.85%-14.40%
60
Neutral
$48.67B4.58-11.27%4.14%2.83%-41.78%
53
Neutral
HK$22.16B-12.84-8.53%11.79%-1226.27%
52
Neutral
HK$1.35B-1.95-7.89%-13.13%-332.19%
47
Neutral
HK$253.04B-47.64-1.74%-0.83%-116.20%
* Communication Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0772
China Literature
21.78
-19.18
-46.83%
HK:0700
Tencent Holdings
442.80
-167.59
-27.46%
HK:9888
Baidu, Inc. Class A
95.90
-10.30
-9.70%
HK:9898
Weibo Corp Class A
53.40
-33.43
-38.50%
HK:1896
Maoyan Entertainment
4.27
-3.48
-44.93%
HK:2390
Zhihu, Inc. Class A
6.94
-5.95
-46.16%

China Literature Corporate Events

China Literature Grants Nearly 8 Million RSUs to Directors and Staff Under 2020 Scheme
Aug 13, 2026
China Literature has granted 7,950,965 restricted share units under its 2020 RSU Scheme to two directors, Huang Yan and Cao Huayi, and other employees of the group. The RSUs are granted at nil consideration and represent an equivalent number of sh...
China Literature Grants 779,812 Share Options Under Employee Incentive Plan
Aug 13, 2026
China Literature has granted a total of 779,812 share options under its Share Option Plan to director Huang Yan and other eligible employees, with an exercise price of HK$22.40 per share and a ten-year validity period. The options will vest in fou...
China Literature Boosts IP-Driven Revenue but Profit Slides on Investment Push
Aug 11, 2026
China Literature reported a 10.7% year-on-year rise in revenue to RMB3.53 billion and an 11.1% increase in gross profit for the first half of 2026, but operating profit and net profit fell sharply due to higher costs and investments, with profit a...
China Literature Sets August Board Meeting to Review Interim Results and Dividend
Jun 23, 2026
China Literature Limited has scheduled a board meeting for August 11, 2026 to review and approve its unaudited interim results for the six months ending June 30, 2026, and to authorize their publication. The board will also consider the possibilit...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 06, 2026